Treating Mental Or Emotional Disorder Patents (Class 607/45)
  • Patent number: 11338144
    Abstract: A multiple output current stimulator circuit with fast turn on time is described. At least one pair of input side and output side transistors is arranged in a current mirror connected to a supply transistor by cascode coupling. The output side transistor supplies stimulation current to an electrode in contact with tissue. An operational amplifier connected to a reference voltage and to the output side transistor drives the supply transistor to maintain the voltage at the output side transistor equal to the reference voltage. The at least one pair of transistors includes multiple pairs of transistors whose output side transistors drive respective electrodes with stimulation currents. The stimulator determines the initiation and duration of stimulation current pulses supplied to each electrode. At circuit activation, large currents are generated which discharge capacitances in the output side transistors causing rapid output side transistor turn on.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: May 24, 2022
    Assignee: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
    Inventor: Edward K. F. Lee
  • Patent number: 11338129
    Abstract: Methods of providing electrical neural modulation to a patient's brain are disclosed herein. The methods involve differentially modulating two or more target regions of the brain. For example, a first target region may be provided with an electrical neural modulation signal that activates that target region while a second target region is provided with an electrical neural modulation signal that suppresses or deactivates that target region. As the implantable pulse generators (IPGs) described herein include independent current sources, such differential modulation can be provided with a single IPG.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: May 24, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventor: Hemant Bokil
  • Patent number: 11338136
    Abstract: A cranial nerve control device includes: goggles worn on a patient head; a functional electric stimulator adapted to apply peripheral nerve stimulation to a patient; a plurality of module guides provided to the goggles; a functional electric stimulator controller adapted to control the functional electric stimulator; a transcranial current stimulator-combined near-infrared spectroscopy measurement module controller adapted to control the transcranial current stimulator-combined functional near-infrared spectroscopy measurement module; and a simulation device connected to both the transcranial current stimulator-combined near-infrared spectroscopy measurement module controller and the functional electric stimulator to provide feedback of a transcranial current stimulation control signal to the transcranial current stimulator and feedback of a functional electrical stimulation control signal to the functional electric stimulator while monitoring the patient brain activity.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: May 24, 2022
    Assignee: CYBERMEDIC CO., LTD.
    Inventors: Ho Choon Jeong, Hyun Hee Lee, Sang Sea Lee, Myoung Choon Kim
  • Patent number: 11331510
    Abstract: A device for magnetic field stimulation of a user's body tissue, is provided which includes an adjustable seating arrangement for the user, at least one magnetic field applicator for generating a pulsating magnetic field in the area of the seating arrangement, control panel for setting one or several parameters of the pulsating magnetic field comprising pulse duration, pulse frequency and pulse amplitude, and/or for adjusting the seating arrangement, and display screen for displaying information. The control panel are designed to manually and/or automatically adjust one or more of the parameters of the magnetic field and/or to adjust the seating arrangement as a function of previously recorded individual information about the user.
    Type: Grant
    Filed: August 5, 2020
    Date of Patent: May 17, 2022
    Assignee: PROF. DR. FISCHER AG
    Inventor: Gerhard Fischer
  • Patent number: 11331474
    Abstract: A low-profile intercranial device adapted for housing a functional neurosurgical implant in manner providing for convenient and reliable grounding to ensure proper impedance measurements includes a static cranial implant including a base cranial implant member including an outer first surface, an inner second surface, and a recess shaped and dimensioned for receiving a functional neurosurgical implant. The low-profile intercranial device includes a plurality of fluid passageways extending between the inner second surface and the recess allowing for the flow of bodily fluid between an external environment of the base cranial implant member and a cavity defined by the recess.
    Type: Grant
    Filed: June 11, 2020
    Date of Patent: May 17, 2022
    Assignee: LONGEVITI NEURO SOLUTIONS LLC
    Inventors: Bradley Rabinovitz, Corbin Clawson, Jimmy Shah
  • Patent number: 11331483
    Abstract: Described is a system for automatic adjustment of neurostimulation. The system controls stimulation of specific neural regions through a neural device positioned on a human subject, while simultaneously performing recordings from the neural device using a targeted arrangement of stimulating electrodes and distinct types of recording electrodes of the neural device. Stimulation of the specific neural regions is adjusted in real-time based on the recordings from the neural device.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: May 17, 2022
    Assignee: HRL Laboratories, LLC
    Inventors: Matthias Ziegler, Jaehoon Choe, Matthew E. Phillips
  • Patent number: 11324427
    Abstract: A method for measuring a neural response to a stimulus. Measurement circuitry is settled prior to a stimulus, by connecting a sense electrode to the measurement circuitry to allow the measurement circuitry to settle towards a bio-electrically defined steady state. Charge is recovered on stimulus electrodes by short circuiting the stimulus electrodes to each other. An electrical stimulus is then applied from the stimulus electrodes to neural tissue, while keeping the sense electrode disconnected from the measurement circuitry. After the stimulus, a delay is imposed during which the stimulus electrodes are open circuited and the sense electrode is disconnected from the measurement circuitry and from the stimulus electrodes. After the delay, a neural response signal present at the sense electrode is measured by connecting the sense electrode to the measurement circuitry.
    Type: Grant
    Filed: April 22, 2019
    Date of Patent: May 10, 2022
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Peter Scott Vallack Single, Dean Michael Karantonis
  • Patent number: 11324916
    Abstract: A wearable device and method for multimodal stimulation of the vagus nerve having a pair of ear pieces, which are placed at least partially within the concha of an individual. Each ear piece has at least on electric stimulator which provides electric current to the ear of the individual. The wearable device also has a connection which provides stimulation instructions to the stimulators. The method for multimodal simulation also includes iterative biometric measurement and stimulation.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: May 10, 2022
    Assignee: Vagus Health Ltd.
    Inventor: Gustaf Kranck
  • Patent number: 11324915
    Abstract: Aspects include a method, system and computer program product for alleviating an episode of a movement disorder condition for a patient. The method comprises deploying an unmanned aerial vehicle (UAV) to a location of a patient based on an occurrence of an episode of a movement disorder condition. A first gross sensory change stimulus is selected with a processor. The first gross sensory change stimulus is projected from the UAV. An attempt to alleviate the episode of the movement disorder condition is performed based at least in part on the projecting of the first gross sensory change stimulus from the UAV. The alleviating of the episode of the movement disorder condition is detected based on the gross sensory change stimulus from the UAV.
    Type: Grant
    Filed: October 31, 2019
    Date of Patent: May 10, 2022
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: James R. Kozloski, Clifford A. Pickover, John J. Rice
  • Patent number: 11324963
    Abstract: Provided herein are, for example, systems and methods of diagnosing and treating depression, in which a transcranial magnetic stimulation (TMS) therapy is administered to a subject in need thereof and measuring a TMS evoked response in the subject, are provided. The systems and methods allow tailoring or optimizing of a treatment protocol for maximal individual benefit, thereby providing an individualized and optimized treatment protocol for psychiatric disorders such as depression.
    Type: Grant
    Filed: April 26, 2017
    Date of Patent: May 10, 2022
    Assignees: The Board of Trustees of the Leland Stanford Junior University, The United States Government as Represented by the Department of Veterans Affairs
    Inventors: Amit Etkin, Corey Keller, Wei Wu
  • Patent number: 11317869
    Abstract: An EEG headpiece includes an array of electrode pins, each electrode pin extending between a proximal end, formed by a proximal end face, and a distal end and including a conducting electrode and a thermoplastic material. The thermoplastic material is arranged at least around a periphery of the electrode pin or is pressable from a hollow space to the periphery. Each electrode pin is equipped for the transmission of energy, especially mechanical vibration energy, from the proximal end face to the thermoplastic material to liquefy at least portions of the thermoplastic material from a solid state to a flowable state, whereby the thermoplastic material is capable of flowing into structures of a tissue portion surrounding the periphery and of forming, after re-solidification of the thermoplastic material, an anchoring of the electrode pin in the tissue portion.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: May 3, 2022
    Assignee: WOODWELDING AG
    Inventors: Marcel Aeschlimann, Jörg Mayer, Mario Weiss, Aymeric Niederhauser
  • Patent number: 11311729
    Abstract: In some examples, a medical device is configured to deliver sub-threshold electrical stimulation therapy to a patient at a stimulation intensity that is significantly less than a perception or paresthesia threshold intensity level for the patient. The medical device may determine the particular intensity level for the patient through a titration process. The medical device may titrate automatically or based upon the input of the patient, a clinician or a physician.
    Type: Grant
    Filed: February 21, 2020
    Date of Patent: April 26, 2022
    Assignee: Medtronic, Inc.
    Inventors: Lachlan Davies, Sheryl McCammon, Andrew J. Cleland, Melanie D Goodman Keiser, Ye Tan, Lisa M. Johanek, Nathan A. Torgerson
  • Patent number: 11315685
    Abstract: A method of building a machine learning pipeline for predicting the efficacy of anti-epilepsy drug treatment regimens is provided.
    Type: Grant
    Filed: January 25, 2017
    Date of Patent: April 26, 2022
    Assignee: UCB BIOPHARMA SRL
    Inventors: Kunal Malhotra, Sungtae An, Jimeng Sun, Myung Choi, Cynthia Dilley, Chris Clark, Joseph Robertson, Edward Han-Burgess
  • Patent number: 11305121
    Abstract: We report a method of automatically titrating an electrical therapy administered to a patient by an implanted medical device to a target dosage, comprising programming the medical device with a programmed electrical therapy comprising a first target value for a first therapy parameter; programming at least one titration parameter for automatically adjusting the first therapy parameter from a first value to the first target value over a titration time period initiating the electrical therapy, wherein the first therapy parameter comprises said first value; and automatically titrating the electrical therapy by making a plurality of adjustments to the value of the first therapy parameter, whereby the first electrical therapy parameter is changed from the first value to the first target value according to a titration function. We also report a medical device system configured to implement the method.
    Type: Grant
    Filed: March 10, 2014
    Date of Patent: April 19, 2022
    Assignee: Flint Hills Scientific, LLC.
    Inventor: Ivan Osorio
  • Patent number: 11298070
    Abstract: A method for monitoring neural activity responsive to a stimulus in a brain, the method comprising: a. applying a first stimulus to one or more of at least one electrode implanted in the brain, the first stimulus comprising a first plurality of bursts of stimulation, b. detecting high frequency oscillations (HFOs) between about 200 Hz and about 500 Hz due to neuronal activity at one or more of the at least one electrode implanted in the brain at least partially during application of the first stimulus; c. determining one or more waveform characteristics of the HFOs; and d. generating a second stimulus comprising a second plurality of bursts of stimulation, wherein one or more waveform characteristics of the second stimulus is dependent on the one of more waveform characteristics of the HFOs; and e. applying the second stimulus to one or more of the at least one electrode implanted in the brain.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: April 12, 2022
    Assignee: DEEP BRAIN STIMULATION TECHNOLOGIES PTY LTD
    Inventors: Nicholas Sinclair, Hugh McDermott, James Fallon, Thushara Perera, Arthur Wesley Thevathasan, Kristian Bulluss
  • Patent number: 11298542
    Abstract: A brain mapping system and methods that allow to predict and monitor the risk of suicide and provide personalized therapy. The brain mapping system and methods detect if brain dysfunctions (injuries) are located in suicidal hubs that trigger increased suicidal ideation and high risk of suicide. The brain mapping technology is suited for different technologies and allows to monitor the effects of therapy, provide precise therapy to decrease the risk of suicide.
    Type: Grant
    Filed: September 16, 2019
    Date of Patent: April 12, 2022
    Assignee: AddBrain Inc
    Inventor: Dorian Aur
  • Patent number: 11298546
    Abstract: This present disclosure provides systems and methods relating to neuromodulation. In particular, the present disclosure provides systems and methods for identifying optimized temporal patterns of spinal cord simulation (SCS) for minimizing variability in patient responses to SCS. The systems and methods of neuromodulation disclosed herein facilitate the treatment of neuropathic pain associated with various disease states and clinical indications.
    Type: Grant
    Filed: December 12, 2018
    Date of Patent: April 12, 2022
    Assignee: Duke University
    Inventors: Warren Grill, John Gilbert
  • Patent number: 11298527
    Abstract: An autonomous neurostimulation unit used in the modulation of the nervous system is provided and has: at least one pair of pads, each formed by at least one inner layer of ceramic; an intermediate layer; and a conductive alloy coating. The material of the layer of coating is different and has different conductivity in each of the pads of the pair. The unit can be used in the modulation of the nervous system, with neurostimulation methods that are adapted to each patient.
    Type: Grant
    Filed: July 4, 2018
    Date of Patent: April 12, 2022
    Inventor: Aitaro Seikai Armenta
  • Patent number: 11291832
    Abstract: Embodiments discussed herein facilitate identification of a target area within a region of a brain for stimulation via one or more BS (Brain Stimulation) electrodes. One example embodiment comprises generating, based on radiological imaging of a region of a brain of a patient and BS electrode lead(s), a patient-specific anatomical model of the region and lead(s); populating the patient-specific anatomical model with neuron models based on associated neuronal densities of at least one of the region or one or more sub-regions of the region; constructing a patient-specific local field potential (LFP) model of the region based on the patient-specific anatomical model and location(s)/orientation(s) of the one or more BS electrode leads; and identifying, via the patient-specific LFP model of the region, a target area within the region for at least one of monitoring or treatment of a medical condition via the one or more BS electrode leads.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: April 5, 2022
    Assignee: Case Western Reserve University
    Inventors: Cameron McIntyre, Nicholas Maling, Scott Lempka
  • Patent number: 11297445
    Abstract: Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache. The disclosed methods may also be used to treat other disorders that may be co-morbid with migraine headaches, such as anxiety disorders. In preferred embodiments of the disclosed methods, one or both of the patient's vagus nerves are stimulated non-invasively. In other embodiments, parts of the sympathetic nervous system and/or the adrenal glands are stimulated.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: April 5, 2022
    Assignee: ELECTROCORE, INC.
    Inventors: Bruce J. Simon, Joseph P. Errico, John T. Raffle
  • Patent number: 11285329
    Abstract: Methods and systems can facilitate visualizing cathodic and anodic stimulation separately. Alternately, the methods and systems may separately visualize stimulation of different neural elements, such as nerve fibers and neural cells. These methods and systems can further facilitate programming an electrical stimulation system for stimulating patient tissue.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: March 29, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Stephen Carcieri, Vikrant Venkateshwar Gunna Srinivasan, Chirag Shah, Peter J. Yoo, Michael A. Moffitt, Sridhar Kothandaraman
  • Patent number: 11285325
    Abstract: In a patient suffering from neural impairment, stimulation is provided to sensory surfaces of the face and/or neck, or more generally to areas of the body that stimulate the trigeminal nerve, while performing an activity intended to stimulate a brain function to be rehabilitated. The simulation may then be continued after the performance of the activity has ceased. It has been found that the patient's performance of the activity is then improved after stimulation has ceased. Moreover, it tends to improve to a greater extent, and/or for a longer time, when the post-activity stimulation is applied, as compared to when post activity stimulation is not applied.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: March 29, 2022
    Inventors: Yuri P. Danilov, Mitchell E. Tyler, Kurt A. Kaczmarek
  • Patent number: 11273310
    Abstract: A system and method for optimizing parameters of a DBS pulse signal for treatment of a patient is provided. In predicting optimal DBS parameters, functional brain data is input into a predictor system, the functional brain data acquired responsive to a sweeping across a multi-dimensional parameter space of one or more DBS parameters. Statistical metrics of brain response are extracted from the functional brain data for one or more ROIs or voxels of the brain via the predictor system, and a DBS functional atlas is accessed, via the predictor system, that comprises disease-specific brain response maps derived from DBS treatment at optimal DBS parameter settings for a plurality of diseases or neurological conditions. One or more optimal DBS parameters are predicted for the patient based on the statistical metrics of brain response and the DBS functional atlas via the predictor system.
    Type: Grant
    Filed: January 22, 2019
    Date of Patent: March 15, 2022
    Assignees: General Electric Company, Albany Medical College
    Inventors: Radhika Madhavan, Jeffrey Ashe, Suresh Joel, Ileana Hancu, Julie Pilitsis, Marisa DiMarzio
  • Patent number: 11266849
    Abstract: A control device (1) for machines (10) for magnetic cerebral or peripheral stimulation with cerebral and bodily navigation, which includes a plurality of keys (2) which can be associated with various functions of the machine (10) and configured for activating, when pressed, a respective function of the machine (10) associated with the respective key (2). The control device (1) also includes a touch screen (3) configured for displaying anatomical information of the subject or patient for a direct viewing from the operator with information relative to the function of the machine (10) which can be activated by the keys (2) and activating at least one further function of the machine (10) associated with a respective icon (7) which can be pressed with the touch screen (3), such as, for example, a stimulation.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: March 8, 2022
    Assignee: EB NEURO S.P.A.
    Inventor: Marco Rossi
  • Patent number: 11260231
    Abstract: Techniques, systems, and devices are disclosed for delivering stimulation therapy to a patient. In one example, a medical device determines a first set of stimulation parameters that define entrainment stimulation pulses configured to entrain electrical activity in a patient. The medical device may control a stimulation generator to generate the entrainment stimulation pulses according to the first set of stimulation parameters. The medical device may further determine a second set of stimulation parameters that define at least one desynchronization stimulation pulse configured to disrupt at least a portion of the electrical activity entrained by the entrainment stimulation pulses. The medical device may subsequently control the stimulation generator to generate the desynchronization stimulation pulse(s) according to the second set of stimulation parameters.
    Type: Grant
    Filed: January 24, 2020
    Date of Patent: March 1, 2022
    Assignee: Medtronic, Inc.
    Inventors: Rene A. Molina, Robert S. Raike, Scott R. Stanslaski
  • Patent number: 11260236
    Abstract: Systems and methods for providing a trial neurostimulation to a patient for assessing suitability of a permanently implanted neurostimulation are provided herein. In one aspect, a trial neurostimulation system includes an EPG affixation device that secures the EPG to the patient when connected to a lead extending through a percutaneous incision to a target tissue location, while allowing for ready removal of the EPG for charging or bathing. In another aspect, the system includes an EPG provided with a multi-purpose connector receptacle through which the the EPG can deliver neurostimulation therapy to an implanted lead or the EPG can be charged. In yet another aspect, the EPG can include a multi-purpose connector receptacle that is alternatingly connectable with a plurality of differing connector to facilitate differing types of therapies with one or more neurostimulation devices, ground patches or various other devices, such as charging or testing devices.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: March 1, 2022
    Assignee: AXONICS, INC.
    Inventors: Prabodh Mathur, Dennis Schroeder, John Woock
  • Patent number: 11253701
    Abstract: The present method and system provides a neuromodulation therapy including receiving a plurality of input data relating to a patient, the input data including brain value measurements and body value measurements. The method and system includes analyzing the input data in reference to reference data generated based on machine learning operations associated with existing patient data and reference database data. Based thereon, the method and system includes electronically determining, a brain malady and a severity value for the patient and electronically generating a treatment protocol for the patient, the treatment protocol includes transcranial stimulation parameters. Therein, the method and system includes applying a transcranial stimulation using the transcranial stimulation parameters based on the treatment protocol.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: February 22, 2022
    Assignee: Evoke Neuroscience, Inc.
    Inventor: David W Hagedorn
  • Patent number: 11259131
    Abstract: The present disclosure relates to charging and recharging systems for compact hearing aids, components thereof, and support devices therefor. The charging and recharging systems generally include a light emitting device, such as an aural insert having a light emitting diode, and a photovoltaic cell disposed on an implanted hearing aid. In operation, the light emitting device is positioned in or near the entrance of the ear canal and transmits light energy across the ear canal towards the implanted hearing aid. The photovoltaic cell receives the light energy and converts the light energy into stored electricity to power the hearing aid.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: February 22, 2022
    Assignee: NANOEAR CORPORATION, INC.
    Inventors: William Clark West, Michael M. Moore, Ron L. Moses, Smruti Mirchandani
  • Patent number: 11253700
    Abstract: An electrode is provided that includes a wire that has a wire diameter of between 75 and 125 microns. The electrode includes a non-electrically-insulated current-application longitudinal segment, which, in the absence of any applied forces, is coiled and has (i) an outer coil diameter of between 3 and 7 times the wire diameter, and (ii) an entire longitudinal length of between 5 and 35 mm. The electrode further includes an electrically-insulated lead longitudinal segment, which has an entire longitudinal length of at least 10 mm, in the absence of any applied forces. Other embodiments are also described.
    Type: Grant
    Filed: July 28, 2021
    Date of Patent: February 22, 2022
    Assignee: RAINBOW MEDICAL LTD.
    Inventors: Yossi Gross, Zev Sohn
  • Patent number: 11237633
    Abstract: One illustrative system disclosed herein includes a processor configured to receive a sensor signal from a neural interface configured to detect an electrical signal associated with a nervous system. The processor is also configured to determine an interaction in with a virtual object in a virtual environment based on the sensor signal. The processor is also configured to determine a haptic effect based at least in part on the interaction with the virtual object in the virtual environment. The processor is also configured to transmit a haptic signal associated with the haptic effect. The illustrative system further includes a haptic output device configured to receive the haptic signal and output the haptic effect.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: February 1, 2022
    Assignee: Immersion Corporation
    Inventor: Juan Manuel Cruz-Hernandez
  • Patent number: 11235148
    Abstract: Portable transdermal electrical stimulation (TES) applicators for modifying a subject's cognitive state by applying stimulation to the subject's skin. One or more electrode may be on the subject's mastoid, and/or on or near the back of the subject's neck. The portable applicators are configured and adapted to be lightweight and may be wearable, and to deliver a high-intensity TES able to evoke or enhance a predetermined cognitive effect to stimulate either the trigeminal, facial and/or cervical plexus. These TES applicators may include a pair of electrodes and a TES control module comprising a processor, a timer and a waveform generator.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: February 1, 2022
    Assignee: Thync Global, Inc.
    Inventors: Jonathan D. Charlesworth, Sumon K. Pal, William J. Tyler, Daniel Z. Wetmore, Isy Goldwasser, Alyssa M. Boasso, Hailey M. Mortimore, Rafal Piersiak
  • Patent number: 11229397
    Abstract: The present disclosure pertains to a system configured to output an indicator representative of effects of stimulation provided to a subject during a sleep session. The indicator is determined based on a combination of the effect of stimulation on sleep restoration, stimulation quality, sleep architecture factors, and/or other information. The indicator is determined using age matched reference information on deep sleep duration and EEG slow wave activity. The contribution to the indicator associated with sleep architecture factors is determined based on age matched reference information including sleep onset latency, wake after sleep onset, total sleep time, micro-arousal count, sleep stage(s) prior to awakening, and/or other information.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: January 25, 2022
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Gary Nelson Garcia Molina, Tsvetomira Kirova Tsoneva, Stefan Pfundtner, Surya Subrahmanya Sreeram Vissapragada Venkata Satya, Anandi Mahadevan, Diane Kosobud
  • Patent number: 11224747
    Abstract: The present disclosure relates generally to systems, methods, and devices for closed loop deep brain stimulation. In particular, a neural signal is measured and provided to software. The software includes a feature generator and a brain network model that takes the neural signal and estimates other neural signals that are not directly measured, and operates as a model of the brain. The software determines a stimulation signal to be sent to stimulating electrodes. Estimated signals by the brain network model are continuously compared to actual signals from the brain. The closed loop feedback system advantageously allows for electrical stimulation levels and patterns to be continuously updated while delivered to a patient.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: January 18, 2022
    Assignee: BATTELLE MEMORIAL INSTITUTE
    Inventors: Chad E. Bouton, Gaurav Sharma, Bradley C. Glenn
  • Patent number: 11207044
    Abstract: An information processing apparatus includes a display control unit. The display control unit is configured to perform control to display a signal source in a superimposed manner on a plurality of biological tomographic images sliced in a predetermined direction, the signal source corresponding to a part of biological data indicating a temporal change of a biological signal, and initially display, in a display region of a screen of a display unit, a biological tomographic image on which a predetermined signal source is superimposed among the plurality of sliced biological tomographic images.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: December 28, 2021
    Assignee: Ricoh Company, Ltd.
    Inventors: Michinari Shinohara, Yutaka Yagiura, Daisuke Sakai
  • Patent number: 11202913
    Abstract: An electrical stimulation system includes a control module that provides electrical stimulation signals to an electrical stimulation lead coupled to the control module for stimulation of patient tissue. The system also includes a sensor to be disposed on or within the body of the patient and to measure a biosignal; and a processor to communicate with the sensor to receive the biosignal and to generate an adjustment to one or more of the stimulation parameters based on the biosignal. The adjustment can be configured and arranged to steer the electrical stimulation signals to stimulate a region of the patient tissue that is different, at least in part, from a region of the patient tissue stimulated prior to the adjustment. Alternatively or additionally, the biosignal is indicative of a particular patient activity and the adjustment is a pre-determined adjustment selected for the particular patient activity.
    Type: Grant
    Filed: June 11, 2019
    Date of Patent: December 21, 2021
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Michael A. Moffitt, Sridhar Kothandaraman
  • Patent number: 11202905
    Abstract: An electrical brain treatment system includes a parenchymal electrode, configured to be implanted in direct physical contact with brain parenchyma or meninges of the brain of a subject identified as at risk of or suffering from a disease; and a cerebrospinal fluid (CSF) electrode, configured to be implanted in a CSF-filled space selected from a ventricular system and a subarachnoid space. Control circuitry is electrically coupled to the parenchymal electrode and the CSF electrode, and is configured to clear a substance from the brain parenchyma into the CSF-filled space of the brain by applying direct current between the parenchymal electrode and the CSF electrode as a series of pulses, with an average amplitude of between 0.25 and 0.5 mA, an average pulse width of between 0.5 and 2 ms, and an average frequency of between 1 and 5 Hz. Other embodiments are also described.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: December 21, 2021
    Assignee: RAINBOW MEDICAL LTD.
    Inventors: Alex Tendler, Yossi Gross
  • Patent number: 11197998
    Abstract: Devices, systems and methods are disclosed that allow a patient to self-treat a medical condition, such as migraine headache, by electrical noninvasive stimulation of a vagus nerve. The system comprises a stimulator that is applied to the surface of the patient's neck. The device housing transmits data to a patient interface device such as a mobile phone or computer relating to the status of a stimulation session. The interface device in turn may communicate with a database contained within other computers, via a network or the internet. The system is designed to address problems that arise particularly during self-treatment, when a medical professional is not present.
    Type: Grant
    Filed: August 8, 2019
    Date of Patent: December 14, 2021
    Assignee: ELECTROCORE, INC.
    Inventors: Bruce J. Simon, Joseph P. Errico, John T. Raffle
  • Patent number: 11191953
    Abstract: Devices, systems and methods are disclosed for electrical stimulation of the vagus nerve to treat or prevent disorders in a patient. The methods comprise transmitting impulses of energy to the vagus nerve according to a treatment paradigm that includes single doses administered 2 to 5 times per day. The treatment paradigm may further comprise one or more daily treatment sessions that each include one or more doses for prophylactic or acute treatment of the patient's condition. Vagus nerve stimulation is used to modulate the release of inhibitory neurotransmitters in the brain, such as GABA, norepinephrine, and/or serotonin.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: December 7, 2021
    Assignee: ELECTROCORE, INC.
    Inventors: Bruce J. Simon, Joseph P. Errico
  • Patent number: 11191952
    Abstract: Implementations described and claimed herein provide thin film devices and methods of manufacturing and implanting the same. In one implementation, a shaped insulator is formed having an inner surface, an outer surface, and a profile shaped according to a selected dielectric use. A layer of conductive traces is fabricated on the inner surface of the shaped insulator using biocompatible metallization. An insulating layer is applied over the layer of conductive traces. An electrode array and a connection array are fabricated on the outer surface of the shaped insulator and/or the insulating layer, and the electrode array and the connection array are in electrical communication with the layer of conductive traces to form a flexible circuit. The implantable thin film device is formed from the flexible circuit according to the selected dialectic use.
    Type: Grant
    Filed: February 18, 2019
    Date of Patent: December 7, 2021
    Assignee: PACESETTER, INC.
    Inventors: John R. Gonzalez, Jeffrey Urbanski, Tommy Cushing
  • Patent number: 11185697
    Abstract: A method of monitoring neural activity responsive to a stimulus in a brain, the method comprising: applying the stimulus to one or more of at least one electrode implanted in a target neural structure of the brain; detecting a resonant response from the target neural structure evoked by the stimulus at one or more of the at least one electrode in or near the target neural structure of the brain; and determining one or more waveform characteristics of the detected resonant response.
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: November 30, 2021
    Assignee: DEEP BRAIN STIMULATION TECHNOLOGIES PTY. LTD.
    Inventors: Nicholas Sinclair, Hugh McDermott, James Fallon, Thushara Perera, Arthur Wesley Thevathasan, Kristian Bulluss
  • Patent number: 11179541
    Abstract: The invention discloses methods and systems for modulation of the central nervous system and more particularly for modulation of brain oscillatory activity and the brain networks that give rise to it. The methods involve using one or more non-invasive stimuli, either alone or in combination, to increase, decrease, or otherwise modulate neural oscillations, the rhythmic and/or repetitive electrical activity generated spontaneously and in response to stimuli by neural tissue in the central nervous system. Various embodiments concern methods and devices for detecting sub-optimal or pathological neural oscillatory patterns, developing treatment protocols to modify the neural oscillations in a desired manner, introducing a non-invasive stimulus or stimuli through one or more sensory pathways to treat the conditions, and for adjusting the treatment protocol to optimize the therapeutic effect of the stimulus or stimuli.
    Type: Grant
    Filed: April 1, 2020
    Date of Patent: November 23, 2021
    Assignee: Phoenix NeuroStim Therapeutics, LLC
    Inventor: Steven Metzger
  • Patent number: 11173306
    Abstract: In electrically stimulating neural tissue it is important to prevent over stimulation and unbalanced stimulation, which would cause damage to the neural tissue, the electrode, or both. It is critical that neural tissue is not subjected to any direct current or alternating current above a safe threshold. Further, it is important to identify defective electrodes, as continued use may result in neural damage and further electrode damage. The present invention presents system and stimulator control mechanisms to prevent damage to neural tissue.
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: November 16, 2021
    Assignee: Second Sight Medical Products, Inc.
    Inventors: Robert Jay Greenberg, Kelly Hobart McClure, James S. Little, Rongqing Dai, Arup Roy, Richard Agustin Castro, John Reinhold, Kea-Tiong Tang, Sumit Yadav, Chunhong Zhou, David Daomin Zhou, Pishoy Maksy
  • Patent number: 11175331
    Abstract: An aging detector for an electrical circuit component and a method for monitoring an aging of a circuit component includes an input of the aging detector recording a parameter of the circuit component, with the aging circuit being configured to, based on the recorded parameter, determine a corresponding response threshold and/or a response or adapt the response threshold and/or the response, and to initiate the response to the parameter exceeding the specific response threshold.
    Type: Grant
    Filed: January 18, 2017
    Date of Patent: November 16, 2021
    Assignee: Robert Bosch GmbH
    Inventors: Daniel Schneider, Franz Dietz
  • Patent number: 11167142
    Abstract: Systems and methods for customizable titration of an implantable neurostimulator are provided. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator includes delivering a first neurostimulation signal with a first set of parameters, increasing a first value of the first neurostimulation signal at a first rate for a first period of time while delivering the first neurostimulation signal, ceasing delivery of the first neurostimulation signal when the first value reaches a first target value, delivering a second neurostimulation signal with a second set of parameters, and increasing the second neurostimulation signal at a second rate for a second period of time while delivering the second neurostimulation signal.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: November 9, 2021
    Assignee: LivaNova USA, Inc.
    Inventors: Scott Stubbs, Imad Libbus, Scott Mazar, Bruce KenKnight, Badri Amurthur
  • Patent number: 11154716
    Abstract: According to an embodiment of a method for providing neural stimulation, activity is sensed, and neural stimulation is automatically controlled based on the sensed activity. An embodiment determines periods of rest and periods of exercise using the sensed activity, and applies neural stimulation during rest and withdrawing neural stimulation during exercise. Other embodiments are provided herein.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: October 26, 2021
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: Imad Libbus, Andrew P. Kramer
  • Patent number: 11141347
    Abstract: Methods and devices are described which allow sound waves to be safely be applied to the eyelid of an eye of a patient or through the eyelid to other structures in the eye or to or through structures in the facial region to effect changes to one or more structures in and around the eye or directly through the cornea or sclera to regions of the eye to treat one or more diseases of the eye.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: October 12, 2021
    Assignee: Olympic Ophthalmics, Inc.
    Inventors: Michael Eric Gertner, Jimin Zhang
  • Patent number: 11141604
    Abstract: Systems and methods of the present disclosure are directed to systems and methods for treating cognitive dysfunction in a subject in need thereof. The system can include eyeglasses, a photodiode positioned to detect ambient light, light sources, and an input device. The system can include a neural stimulation system that retrieves a profile and selects a light pattern having a fixed parameter and a variable parameter. The neural stimulation system can set a value of the variable parameter of the light pattern, construct an output signal, and then provide the output signal to the light sources to direct light towards the fovea.
    Type: Grant
    Filed: May 6, 2019
    Date of Patent: October 12, 2021
    Assignee: Cognito Therapeutics, Inc.
    Inventors: Zachary John Hambrecht Malchano, Martin Warren Williams
  • Patent number: 11141582
    Abstract: Methods and devices for stimulating a nerve in a patient include emitting an electrical signal near a spinal nerve within the patient such that the patient experiences at least some pain relief. The methods include varying an electric field such that burst periods and constant periods are created. The electric field has a charge that alternates between positive and negative during the burst periods and a charge with a magnitude of zero during the constant periods.
    Type: Grant
    Filed: September 2, 2020
    Date of Patent: October 12, 2021
    Assignee: ELECTROCORE, INC
    Inventors: Bruce J. Simon, Joseph P. Errico, John T. Raffle
  • Patent number: 11139861
    Abstract: An electronic device may include a transmission circuit and an inductive element. The inductive element may be configured to generate a wireless communication signal based on a current. The transmission circuit may be configured to output the current based on a supply voltage; to increase an intensity of the current, from zero to an increased intensity that is less than or equal to a target value, by alternately repeating a first increase and a first decrease of the intensity of the current, in a first time interval; to decrease the intensity of the current, from the increased intensity to zero, by alternately repeating a second increase and a second decrease of the intensity of the current, in a second time interval.
    Type: Grant
    Filed: August 24, 2020
    Date of Patent: October 5, 2021
    Inventors: Youngjin Moon, Hyoungseok Oh, Sungwoo Lee
  • Patent number: RE48907
    Abstract: A method for manufacturing a lead includes forming an elongated multi-lumen conductor guide defining a central stylet lumen and a plurality of conductor lumens arranged around the stylet lumen. The multi-lumen conductor guide is twisted to form at least one helical section where the plurality of conductor lumens each forms a helical pathway around the stylet lumen. Each of the helical pathways of the at least one helical section has a pitch that is no less than 0.04 turns per centimeter.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: February 1, 2022
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: Andrew DiGiore, Thomas Lopez